Skip to main content
. 2014 Jan 1;23(1):69–76. doi: 10.1089/jwh.2013.4367

Table 3.

Factors Associated with Poor Short Physical Performance Battery Score

Characteristic SPPB≤9 n=13 SPPB>9 n=52 p-value
Demographic variables
 Age (years)
55 (48–56)
48 (44–54)
0.06
 Race/ethnicity
  Black
9 (69)
35 (67)
1.0
  White
1 (8)
5 (10)
 
  Hispanic
2 (15)
9 (17)
 
  Other
1 (8)
3 (6)
 
 Current cigarette smoker
8 (62)
14 (27)
0.03
 Current illicit drug use (n=64)
0
6 (12)
0.33
General medical variables
 Body mass index
30.5 (25.6–34.5)
27.9 (23.8–32.4)
0.38
 Hypertension
9 (69)
23 (44)
0.13
 Hepatitis C infection
6 (46)
12 (23)
0.16
 Hyperlipidemia
4 (31)
14 (27)
0.74
 Diabetes
6 (46)
10 (19)
0.07
 Number of comorbid medical conditionsa
  0
1 (8)
15 (29)
0.01
  1–2
7 (54)
33 (63)
 
  3 or more
5 (38)
4 (8)
 
HIV variables
 Nadir CD4 count (cells/mm3) (n=61)
202 (70–223)
200.5 (125–269.5)
0.51
 Current CD4 count (cells/mm3)
595 (471–826)
678.5 (427–831.5)
0.95
 Current HIV viral load ≤75 copies/mL
10 (77)
48 (92)
0.14
Component scores of Short Physical Performance Battery
 Balance
4 (3–4)
4 (4–4)
0.054
 Walking speed
3 (3–3)
4 (4–4)
<0.0001
 Chair stand time
2 (1–3)
4 (3.5–4)
<0.0001
Inflammatory Variables
 sTNFR1 (ng/mL) (n=62)
2.0 (1.7–2.5)
1.6 (1.3–1.8)
0.09
 sCD14 (ug/mL) (n=62)
2.0 (1.5–2.2)
1.7 (1.6–2.0)
0.84
 TGFB1 (ng/mL) (n=59)
25.4 (19.1–47.8)
32.2 (17.5–40.7)
0.98
 IL-6 (pg/mL) (n=62)
1 (0–3)
0 (0–1)
0.048
 HA (ng/mL) (n=61)
1.5 (0–12.6)
0.2 (0–2.6)
0.17
 LPS (endotoxin unit) (n=61) 0.8 (0.3–1.0) 0.8 (0.4–1.2) 0.54

Results presented as number (percent) or median (interquartile range).

a

Includes diagnosis of hypertension, hepatitis C, hyperlipidemia, diabetes, and coronary artery disease.

CD4, CD4 T-cell.